SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens
1 references·16 citing·45 second hop
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens (1988)Radioligand binding evidence implicates t…Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Evidence for 5-HT2 involvemen…Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential (2023)Identification of 5-HT2A rece…The promises and perils of psychedelic pharmacology for psychiatry (2022)The promises and perils of ps…Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)Psychedelics in Psychiatry: N…Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution (2017)Looking for the Self: Phenome…Clinical applications of hallucinogens: A review. (2016)Clinical applications of hall…The hallucinogenic world of tryptamines: an updated review (2015)The hallucinogenic world of t…Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) (2015)Receptor interaction profiles…Recent advances in the neuropsychopharmacology of serotonergic hallucinogens (2014)Recent advances in the neurop…The behavioral pharmacology of hallucinogens (2007)The behavioral pharmacology o…Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex (2007)Mechanism of the 5-hydroxytry…Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant (2006)Increased frontal and paralim…A Single Dose of Lysergic Acid Diethylamide Influences Gene Expression Patterns within the Mammalian Brain (2002)A Single Dose of Lysergic Aci…Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans (2000)Psychological and Physiologic…Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors (2000)Behavioral Evidence for Inter…Noradrenergic and Serotonergic Function in Posttraumatic Stress Disorder (1997)Noradrenergic and Serotonergi…3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)3,4‐Methylenedioxymethampheta…Psychophysiologic Assessment of Posttraumatic Stress Disorder Imagery in Vietnam Combat Veterans (1987)Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: Three studies in reliability and validity. (1988)Dissociation, somatization, and affect dysregulation: the complexity of adaptation of trauma (1996)Neuroanatomical circuits modulating fear and anxiety behaviors (2003)Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder (2007)Psychobiological mechanisms of resilience: Relevance to prevention and treatment of stress-related psychopathology (2007)Hallucinogens (2004)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies (2017)Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness (2018)N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function (2018)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low (1997)Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity (1998)Memory deficits associated with recreational use of "ecstasy" (MDMA) (1999)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Psychedelics not linked to mental health problems or suicidal behavior: A population study (2015)Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years (2016)Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways (2017)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Looking for Spinoza: Joy, Sorrow, and the Feeling Brain (2004)Meditation experience is associated with increased cortical thickness (2005)Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion (2011)The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization (2016)Schedules of reinforcement. (1957)Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (2003)STAI manual for the State-trait anxiety inventory (1970)Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies (2001)Effects of MDMA on sociability and neural response to social threat and social reward (2009)Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects (2019)The size and burden of mental disorders and other disorders of the brain in Europe 2010 (2011)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity (2022)A non-hallucinogenic LSD analog with therapeutic potential for mood disorders (2023)Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review (2023)Broadband Cortical Desynchronization Underlies the Human Psychedelic State (2013)Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution (2016)Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function (2018)Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model (2012)Classic hallucinogens in the treatment of addictions (2015)
this work references cited by second hop

References

  • 1984Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents631 cited

Cited by

  • 1997Noradrenergic and Serotonergic Function in Posttraumatic Stress Disorder322 cited
  • 2014Recent advances in the neuropsychopharmacology of serotonergic hallucinogens311 cited
  • 2015The hallucinogenic world of tryptamines: an updated review291 cited
  • 19943,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans289 cited
  • 2000Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans245 cited
  • 2006Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant241 cited
  • 2020Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms231 cited
  • 2007Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex229 cited
  • 2007The behavioral pharmacology of hallucinogens225 cited
  • 2015Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)217 cited
  • 2017Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution206 cited
  • 2016Clinical applications of hallucinogens: A review.201 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2022The promises and perils of psychedelic pharmacology for psychiatry194 cited
  • 2023Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential178 cited
  • 2000Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors164 cited
  • 2002A Single Dose of Lysergic Acid Diethylamide Influences Gene Expression Patterns within the Mammalian Brain163 cited